dNerva® TLD ose bronchoscopic procedure e fa'alavelaveina ai neura pulmonary i totonu o le mama e fa'aitiitia ai a'afiaga fa'afoma'i o neural hyperactivity. E tutusa lelei le masini ma anticholinergics (le vasega autu o vailaʻau COPD) e faʻaaogaina i aso uma e pulea ai faʻamaoniga, o le tasi taimi o le dNerva faʻataʻitaʻiga e mafai ona faʻaitiitia le faʻalavelave faʻafuaseʻi, faʻaleleia auga, ma faʻamautu galuega mama.
Ole 300th dNerva TLD togafitiga na tupu ile masina nei. Dr. Gerard Criner, Taitaifono ma Polofesa, Thoracic Medicine and Surgery i le Lewis Katz School of Medicine i le Temple University na togafitia le 20 maʻi i le AIRFLOW-3 faʻataʻitaʻiga. "Afai e mafai ona matou fesoasoani i tagata mamaʻi e faʻamautu a latou COPD faʻamaoniga ma taofia i latou mai le falemaʻi, o le a manuia ai tagata mamaʻi, o latou tausi maʻi, ma faʻaitiitia ai le avega i luga o le soifua maloloina faiga faʻapea foi," o lana tala lea. COPD faʻateleina o loʻo faʻatusalia pe tusa ma le lua vaetolu o le tau atoa o le tausiga COPD, faʻatatau ile $49B i tausaga taʻitasi i le US
O lenei masina e faʻailogaina foi se faʻailoga taua tele i le AIRFLOW-3 faʻataʻitaʻiga. Polofesa Pallav Shah, Fomai Faufautua i le Chelsea & Westminster ma le Royal Brompton Hospitals i Lonetona ma le Polofesa o Respiratory Medicine i le Imperial College o le taʻimua e lesitala i le faamasinoga. Na ia faia le 200th AIRFLOW-3 faʻataʻitaʻiga i se tagata maʻi i le COPD feololo i le ogaoga, faʻailoga maualuga, ma se talaʻaga o faʻalavelave COPD e ui lava i le lelei o le pulega faafomaʻi. "O le tele o gasegase COPD e mafatia i le le lelei o le olaga ona o le faʻateleina o le COPD faʻateleina" o lana tala lea. "O le AIRFLOW-3 faʻataʻitaʻiga o se avanoa fiafia e iloilo ai se faʻataʻitaʻiga e tasi le taimi i fafo e mafai ona faʻaitiitia ai le faʻalavelave COPD ma faʻaleleia le mautu o falemaʻi."
Na fa'amautu talu ai nei e le Kamupani le $50 miliona fa'aopoopo o aitalafu ma fa'atupega tutusa ma le Innovatus Capital Partners, LLC, lea o le a fa'aaogaina e fa'amae'a ai le AIRFLOW-3 fa'ata'ita'iga ma maua ai le faamaoniga a le US FDA.
OA MEA E AVEA MAI LENEI TUSI:
- Na ia faia le 200th AIRFLOW-3 faʻataʻitaʻiga i se tagata maʻi ma COPD feololo i le ogaoga, faʻailoga maualuga, ma se talaʻaga o faʻalavelave COPD e ui lava i le lelei o le pulega faafomaʻi.
- Gerard Criner, Taitaifono ma Polofesa, Thoracic Medicine and Surgery i le Lewis Katz School of Medicine i le Temple University na togafitia 20 tagata gasegase i le AIRFLOW-3 faʻataʻitaʻiga.
- E tutusa lelei le masini ma le anticholinergics (le vasega autu o fualaau COPD) e ave i aso uma e pulea ai faʻamaoniga, o le tasi taimi o le dNerva faʻataʻitaʻiga e mafai ona faʻaitiitia le faʻalavelave faʻafuaseʻi, faʻaleleia auga, ma faʻamautu le gaioiga o le mama.
